UPDATED May 01, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$395.13 | -3.4% | 29.8% | US$2.9t | US$476.88 | PE34.1x | E12.7% | 0.8% | Software | ||
GOOGL | US$163.80 | 2.9% | 55.4% | US$2.0t | US$188.49 | PE24.6x | E12.3% | 0.5% | Media | ||
AMZN | US$178.86 | 1.3% | 72.6% | US$1.8t | US$215.35 | PE49.4x | E20.8% | n/a | Retail | ||
META | US$439.10 | -11.0% | 85.3% | US$1.1t | US$521.49 | PE24.3x | E12.2% | 0.5% | Media | ||
LLY | US$776.75 | 6.1% | 80.1% | US$703.3b | US$845.32 | PE113.9x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$790.00 | 0.9% | 59.3% | NT$20.5t | NT$912.98 | PE23.9x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,242.86 | -1.1% | 102.7% | US$602.6b | US$1,500.96 | PE49.7x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.897.70 | 2.2% | 59.8% | kr.4.0t | kr.904.20 | PE47.9x | E14.7% | 1.0% | Pharmaceuticals & Biotech | ||
JPM | US$191.86 | -0.6% | 41.1% | US$550.7b | US$206.49 | PB1.8x | E-1.4% | 2.4% | Banks | ||
WMT | US$58.85 | -1.7% | 17.2% | US$478.3b | US$65.08 | PE30.6x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$116.03 | -4.1% | 7.5% | US$466.3b | US$130.64 | PE13.9x | E1.7% | 3.3% | Energy | ||
UNH | US$484.11 | -0.7% | -1.1% | US$445.0b | US$567.36 | PE29x | E19.1% | 1.6% | Healthcare | ||
MA | US$442.07 | -4.4% | 17.9% | US$419.7b | US$513.98 | PE34.7x | E12.0% | 0.6% | Diversified Financials | ||
700 | HK$347.20 | 0.9% | 2.3% | HK$3.2t | HK$417.77 | PE26x | E15.0% | 1.0% | Media | ||
PG | US$163.40 | 0.5% | 4.6% | US$385.2b | US$170.26 | PE26x | E7.2% | 2.5% | Household | ||
A005930 | ₩77,500.00 | -1.4% | 18.5% | ₩516.3t | ₩102,486.49 | PE26.7x | E23.7% | 1.9% | Tech | ||
JNJ | US$151.18 | 1.8% | -7.2% | US$348.4b | US$173.26 | PE19x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$331.97 | -0.3% | 13.3% | US$331.2b | US$384.83 | PE21.7x | E4.2% | 2.7% | Retail | ||
MRK | US$128.80 | 1.4% | 8.9% | US$327.3b | US$141.31 | PE141.5x | E25.6% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$722.22 | -0.2% | 47.4% | US$320.6b | US$776.41 | PE47.1x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$114.63 | -0.6% | 20.9% | US$312.6b | US$137.02 | PE29.6x | E14.7% | 1.4% | Software | ||
CVX | US$159.63 | -2.4% | 1.8% | US$297.2b | US$182.49 | PE14.5x | E2.6% | 4.1% | Energy | ||
600519 | CN¥1,705.00 | 0.7% | -3.2% | CN¥2.1t | CN¥2,157.44 | PE27.5x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
BAC | US$36.95 | -3.6% | 32.6% | US$291.2b | US$39.95 | PB1.1x | E6.1% | 2.6% | Banks |